Session 8: Health Maintenance for Patients with CLL

Co-Chair(s)

• 

  Carsten Niemann, MD, PhD

  Associate Professor
  Rigshospitalet, Copenhagen University Hospital
  Copenhagen, Hovedstaden, Denmark
• 

  Brian Koffman, MD

  Co-Founder, Executive Vice President, Chief Medical Officer
  CLL Society, Inc., Chula Vista
  Claremont, California, United States

Presentations:

• 15:00 - 15:10 CEST

  Vaccination and Infection Prevention
  

  Speaker: Stephen S. Opat, MBBS – Monash University
• 15:10 - 15:20 CEST

  Optimizing CLL Care: Comedications, Lifestyle, and Patient Well-Being
  

  Speaker: Tamar Tadmor, MD – Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine
• 15:20 - 15:30 CEST

  Comorbidities and Impact on CLL Management
  

  Speaker: Emelie Curovic Rotbain, MD, PhD – Rigshospitalet, Copenhagen University Hospital
• 15:30 - 15:40 CEST

  Panel Discussion With Interactivity and Audience Q&A
• 15:40 - 15:45 CEST

  MVA-based GEO-CM04S1 vaccine results in improved cellular immune response in patients with chronic lymphocytic leukemia (CLL) compared with mRNA-based vaccine: initial results of a Phase II randomized study
  

  Primary Author / Presenter: Alexey V. Danilov, MD, PhD – Department of Hematology and Transplantation, City of Hope National Medical Center
• 15:45 - 15:55 CEST

  Binet/Rai Medal Presentation